Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...

Durable reprogramming of human T cells may now be possible thanks to a new technique based on the CRISPRoff and CRISPRon methodology. Researchers from the Arc Institute, Gladstone Institutes, and the ...

Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA. Human cells that have been edited with the new retron-based gene editing technology. Orange dots mark ...

SAN FRANCISCO, Oct 22 (Reuters) - Biotech firm Metagenomi (MGX.O), opens new tab said it is using artificial intelligence chips from Amazon.com's (AMZN.O), opens new tab cloud computing unit to power ...

Long interspersed nuclear element-1 (LINE-1 or L1) is the only active, self-copying genetic element in the human genome—comprising about 17% of the genome. It is commonly called a "jumping gene" or ...

Faulty versions of the LMNA gene can cause a wide range of health problems, including heart muscle disease (dilated cardiomyopathy) and muscle weakness (muscular dystrophies). Many of these diseases ...

Researchers in Mexico are turning their focus towards a revolutionary technique to enhance crop resilience. According to News Arena India, the International Maize and Wheat Improvement Center, also ...

OPEN TO DEBATE: As modern warfare becomes increasingly automated and reliant on artificial intelligence, the question of who, or what, should have ultimate control over lethal decision-making systems ...

When baby KJ Muldoon was treated with a personalized gene editing treatment back in February, scientists behind the effort envisioned a world where all patients born with genetic diseases could have ...

In 2023, FDA approved one CRISPR/Cas9-based gene therapy to treat sickle cell disease, which marks a significant milestone in the translation of genome editing technologies into clinical therapeutics.

At the WIRED Health summit last week, Harvard biochemist and gene-editing pioneer David Liu said that later this year his lab plans to report on a single gene-editing strategy that could treat many ...